
IAOCR has been committed to transforming the world of clinical research for over a decade. Driving this through the adoption of global best-practice standards for the enhancement and advancement of people and processes in the clinical research industry.

Suki Balendra’s career has spanned academia, industry, central government and currently the UK’s NHS; working with the pharmaceutical Industry. She is working at Imperial College Healthcare NHS Trust as part of National Institute for Health Research (NIHR) Clinical Research Network (CRN), Suki’s role is focused on growing the commercial research opportunities for North West London.

Quality is the backbone of the clinical research industry, and IAOCR is dedicated to upholding and adhering to the highest quality standards. Whilst doing so, IAOCR holds an integral independence from the industry to insure a suitable degree of impartiality, however in spite of this it remains important to be in constant dialogue and listen to the industry.

The growth and widespread use of electronic data capture was one of the factors behind the release of European Medicine Agency’s Reflection Paper on Risk Based Quality Management in Clinical Trials in 2013. Included in the glossary of this document is the definition of Central Monitoring.

IAOCR is delighted to announced that LMK Clinical Research Consulting (LMK) has been awarded IAOCR Certified Academy Partners status for their pioneering of Trial Master File University (TMF University). TMF is the foundation of every clinical trial and holds critical importance to the outcome of clinical trials, yet previously there were no international standards for individuals to work by.

Life has fundamentally shifted for everyone since we learned about COVID-19 and the year has been frequently (and fairly) referred to as ‘unprecedented’. As we mark this unusual anniversary it offers an important opportunity to reflect on how it has affected us and what we have learned from it.

World Health Day is an opportunity to reflect and consider the global health environment and this year the WHO’s focus is on building a fairer, healthier world for everyone. The importance of this day is extenuated following the global impact of the COVID-19 pandemic, which has united scientists and the global community in the fight against this deadly virus, but has also served to highlight the extreme disparities that exist in basic global healthcare worldwide.

You wouldn’t board a flight with an unlicensed pilot? You wouldn’t drive a car without insurance? Why would you entrust your clinical research in someone who hasn’t proven and safeguarded their capabilities? Don’t Risk It!

Quality is the backbone of the clinical research industry, and IAOCR is dedicated to upholding and driving the industry to adhere to the highest quality standards. Whilst doing so, IAOCR necessarily remains independent, in order to ensure a suitable degree of impartiality, however in spite of this it remains important to be in constant dialogue and listen to the industry.